Brain Health in Breast Cancer Survivors (NCT04297020)
Brain Health in Breast Cancer Survivors: Interaction of Menopause and Endocrine Therapy
🩺 Plain-English Summary (8th-Grade Level)
Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs readily cross the blood brain barrier and interfere with the action of estrogen in the brain. Estrogen supports cognition and menopausal status is closely linked to cognitive health in women. This has raised concern that anti-estrogen ETs may affect cognition and brain health in breast cancer survivors. However, evidence across existing studies is inconsistent and these effects remain poorly understood. The incomplete understanding of the effects of ET are likely due to limitations of earlier studies - namely, the under-appreciation of the role of menopausal status and insensitivity of standard cognitive measures. This research project will address these earlier limitations by specifically comparing ET effects by menopausal status, and using highly sensitive, task-related functional magnetic resonance imaging (fMRI) measures to assess the effects of ET on brain function.
Who can join: Review the eligibility criteria below.
Location: University of California at Los Angeles — Los Angeles, California
Age range: 35 Years to 65 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of California at Los Angeles — Los Angeles, California
📞 Contact the Study Coordinator
Phone: (310) 825-2719
Email: KVanDyk@mednet.ucla.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cognitive Impairment
- The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition — Salt Lake City, Utah
- Cognitive Screening Made Easy for PCPs - R33 Phase — Austin, Texas
- Anticipating Decline and Providing Therapy — Winston-Salem, North Carolina
- Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium — Los Angeles, California
- COgnitive and Physical Exercise to Improve Outcomes After Surgery (COPE-iOS) Study — Nashville, Tennessee
- The Care for America's Aging Study — Boston, Massachusetts
Explore by condition: All Cognitive Impairment clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.